AAAAAA

   
Results: 1-25 | 26-38 |
Results: 26-38/38

Authors: GUTIERREZ MI BHATIA K DIEZ B MURIEL FS EPELMAN S DEANDREAS ML HUPPI K MAGRATH I
Citation: Mi. Gutierrez et al., PROGNOSTIC-SIGNIFICANCE OF P53 MUTATIONS IN SMALL NON-CLEAVED CELL LYMPHOMAS, International journal of oncology, 4(3), 1994, pp. 567-571

Authors: BHATIA K SPANGLER G HUPPI K SIWARSKI D MAGRATH I
Citation: K. Bhatia et al., LOSS OF WILD-TYPE C-MYC IN BURKITTS LYMPHOMAS, Journal of cellular biochemistry, 1994, pp. 198-198

Authors: JAIN VK SEEM N GESELOVITZ D NECKERS D MAGRATH I
Citation: Vk. Jain et al., INHIBITION OF IMMUNOGLOBULIN HEAVY-CHAIN (MU)-ENHANCER ACTIVITY BY A DNA OLIGOMER DIRECTED AT THE (MU)E4-MOTIF INHIBITS C-MYC TRANSCRIPTIONIN BURKITTS-LYMPHOMA, Experimental hematology, 22(8), 1994, pp. 718-718

Authors: FAN SJ ELDEIRY WS BAE I FREEMAN J JONDLE D BHATIA K FORNACE AJ MAGRATH I KOHN KW OCONNOR PM
Citation: Sj. Fan et al., P53 GENE-MUTATIONS ARE ASSOCIATED WITH DECREASED SENSITIVITY OF HUMANLYMPHOMA-CELLS TO DNA-DAMAGING AGENTS, Cancer research, 54(22), 1994, pp. 5824-5830

Authors: WEINTRAUB M ADDE M SHAD A HORAK I SEIBEL N NEELY J MAGRATH I
Citation: M. Weintraub et al., PROFOUND PERIPHERAL NEUROPATHY ASSOCIATED WITH THE ADMINISTRATION OF COLONY-STIMULATING FACTORS, Blood, 84(10), 1994, pp. 10000128-10000128

Authors: GREVER MR BHATIA K GIAVAZZI R HOLLINGSHEAD M MAGRATH I MALSPEIS L MAYO J SHORES R
Citation: Mr. Grever et al., EXPERIMENTAL THERAPEUTIC AGENTS IN AN AIDS-RELATED SCID MOUSE MODEL, Blood, 84(10), 1994, pp. 10000447-10000447

Authors: FRANKLIN JL NARESH KN CACERES E BHATIA K OCONOR G MAGRATH I
Citation: Jl. Franklin et al., P53 EXPRESSION, BCL-2 EXPRESSION AND EBV ASSOCIATION IN PERUVIAN NASAL LYMPHOMAS, Blood, 84(10), 1994, pp. 10000522-10000522

Authors: MAGRATH I LITVAK J
Citation: I. Magrath et J. Litvak, CANCER IN DEVELOPING-COUNTRIES - OPPORTUNITY AND CHALLENGE, Journal of the National Cancer Institute, 85(11), 1993, pp. 862-874

Authors: BHATIA K HUPPI K SPANGLER G SIWARSKI D IYER R MAGRATH I
Citation: K. Bhatia et al., POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS, Nature genetics, 5(1), 1993, pp. 56-61

Authors: BHATIA K GOLDSCHMIDTS W GUTIERREZ M GAIDANO G DALLAFAVERA R MAGRATH I
Citation: K. Bhatia et al., HEMIZYGOSITY OR HOMOZYGOSITY - A REQUIREMENT FOR SOME BUT NOT OTHER P53 MUTANT PROTEINS TO ACCUMULATE AND EXERT A PATHOGENETIC EFFECT, The FASEB journal, 7(10), 1993, pp. 951-956

Authors: OCONNOR PM JACKMAN J JONDLE D BHATIA K MAGRATH I KOHN KW
Citation: Pm. Oconnor et al., ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN CELL-CYCLE ARREST AND RADIOSENSITIVITY OF BURKITTS-LYMPHOMA CELL-LINES, Cancer research, 53(20), 1993, pp. 4776-4780

Authors: SHAD A ADDE M MAGRATH I
Citation: A. Shad et al., RESULTS OF NCI PROTOCOL 77-04 FOR TREATMENT OF LYMPHOBLASTIC LYMPHOMAIN CHILDREN, Blood, 82(10), 1993, pp. 10000387-10000387

Authors: SHAD A BHATIA K HAMDY N MUELLER B PIZZO P PENG JW KNUTSEN T JAFFE E MAGRATH I
Citation: A. Shad et al., MOLECULAR CHARACTERIZATION OF PEDIATRIC HIV-ASSOCIATED NON-HODGKINS-LYMPHOMAS, Blood, 82(10), 1993, pp. 10000578-10000578
Risultati: 1-25 | 26-38 |